نتائج البحث - "Martinez Marti, Alex"

1

دورية أكاديمية

BRAF mutational status is associated with survival outcomes in locally advanced resectable and metastatic NSCLC

المؤلفون: Robado de Lope, Lucía, Serna-Blasco, Roberto, Diz Tain, Pilar, MARTINEZ-MARTI, ALEX, provencio, mariano, Nadal, Ernest, Massuti, Bartomeu

المساهمون: Institut Català de la Salut, Provencio M Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain. Robado de Lope L, Serna-Blasco R Instituto de Investigación Sanitaria Puerta de Hierro-Segovia de Arana, Majadahonda, Madrid, Spain. Nadal E Institut Català d’Oncologia (ICO), Institut d’Investigació Biomèdica de Bellvitge (IDIBELL), L’Hospitalet de Llobregat, Barcelona, Spain. Diz Tain P Complejo Asistencial Universitario de León, León, Spain. Massuti B Hospital General Universitario de Alicante, Alicante, Spain. Martínez-Martí A Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: Avaluació de resultats (Assistència sanitària), Anomalies cromosòmiques, Pulmons - Càncer - Immunoteràpia, Pulmons - Càncer - Aspectes genètics, PHENOMENA AND PROCESSES::Genetic Phenomena::Genetic Variation::Mutation, DISEASES::Neoplasms::Neoplasms by Site::Thoracic Neoplasms::Respiratory Tract Neoplasms::Lung Neoplasms::Bronchial Neoplasms::Carcinoma, Bronchogenic::Carcinoma, Non-Small-Cell Lung, Other subheadings::Other subheadings::Other subheadings::/drug therapy, ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Therapeutics::Biological Therapy::Immunomodulation::Immunotherapy, AND EQUIPMENT::Diagnosis::Prognosis::Treatment Outcome::Progression-Free Survival, FENÓMENOS Y PROCESOS::fenómenos genéticos::variación genética::mutación, ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias torácicas::neoplasias del tracto respiratorio::neoplasias pulmonares::neoplasias de los bronquios::carcinoma broncogénico::carcinoma de pulmón de células no pequeñas, Otros calificadores::Otros calificadores::Otros calificadores::/farmacoterapia, TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::terapéutica::terapia biológica::inmunomodulación::inmunoterapia, DIAGNÓSTICOS Y TERAPÉUTICOS::diagnóstico::pronóstico::resultado del tratamiento::supervivencia libre de progresión

وصف الملف: application/pdf

العلاقة: Lung Cancer;194; https://doi.org/10.1016/j.lungcan.2024.107865Test; info:eu-repo/grantAgreement/EC/H2020/875160; Provencio M, Robado de Lope L, Serna-Blasco R, Nadal E, Diz Tain P, Massuti B, et al. BRAF mutational status is associated with survival outcomes in locally advanced resectable and metastatic NSCLC. Lung Cancer. 2024 Jun 26;194:107865.; https://hdl.handle.net/11351/11668Test

الإتاحة: https://doi.org/10.1016/j.lungcan.2024.107865Test
https://hdl.handle.net/11351/11668Test

View record in BASE

2

دورية أكاديمية

Perioperative Nivolumab and Chemotherapy in Stage III Non-Small-Cell Lung Cancer

مصطلحات موضوعية: Càncer

وصف الملف: application/pdf

العلاقة: New England Journal of Medicine, 2023; Provencio Pulla, Mariano Nadal, Ernest González Larriba, Jose Luís Martínez Martí, Alex Bernabé, Reyes Bosch Barrera, Joaquim Casal Rubio, Joaquín Calvo, Virginia Insa, Amelia Ponce, Santiago Reguart, Noemí De Castro, Javier Mosquera, Joaquín Cobo, Manuel Aguilar, Andrés López Vivanco, Guillermo Camps, Carlos López Castro, Rafael Morán, Teresa Barneto, Isidoro Rodríguez Abreu, Delvys Serna Blasco, Roberto Benítez, Raquel Aguado de la Rosa, Carlos Palmero, Ramón Hernando Trancho, Florentino Martín López, Javier Cruz Bermúdez, Alberto Massuti, Bartomeu Romero Alfonso, Atocha 2023 Perioperative Nivolumab and Chemotherapy in Stage III Non-Small-Cell Lung Cancer New England Journal of Medicine; https://hdl.handle.net/10550/89125Test; 161070

الإتاحة: https://doi.org/10.1056/NEJMoa2215530Test
https://hdl.handle.net/10550/89125Test

View record in BASE

3

دورية أكاديمية

Dynamic changes in circulating tumor assessed by shallow whole-genome sequencing associate with clinical efficacy of checkpoint inhibitors in

مصطلحات موضوعية: Aneuploidy, Cfdna, Immune checkpoint inhibitors, Liquid biopsy, NSCLC, Shallow whole-genome sequencing

وصف الملف: application/pdf

العلاقة: Instituto de Salud Carlos III PI22/01585; Instituto de Salud Carlos III PI20/00987; Molecular Oncology; Vol. 17 (march 2023), p. 779-791; https://ddd.uab.cat/record/281278Test; urn:10.1002/1878-0261.13409; urn:oai:ddd.uab.cat:281278; urn:pmcid:PMC10158763; urn:pmc-uid:10158763; urn:pmid:36852704; urn:oai:pubmedcentral.nih.gov:10158763; urn:articleid:18780261v17p779

الإتاحة: https://ddd.uab.cat/record/281278Test

View record in BASE

النص الكامل

4

دورية أكاديمية

Systemic and Intracranial Outcomes With First-Line Nivolumab Plus Ipilimumab in Patients With Metastatic NSCLC and Baseline Brain Metastases From CheckMate 227 Part 1

المساهمون: Bristol Myers Squibb Foundation

مصطلحات موضوعية: NSCLC, Nivolumab, Ipilimumab, Brain metastases, Intracranial outcomes

وصف الملف: application/pdf

العلاقة: Publisher's version; The underlying dataset has been published as supplementary material of the article in the publisher platform at https://doi.org/10.1016/j.jtho.2023.04.021Test; https://doi.org/10.1016/j.jtho.2023.04.021Test; Sí; Journal of Thoracic Oncology 18(8): 1055-1069 (2023); http://hdl.handle.net/10261/353291Test

الإتاحة: https://doi.org/10.1016/j.jtho.2023.04.021Test
http://hdl.handle.net/10261/353291Test

View record in BASE

النص الكامل

5

دورية أكاديمية

ONCOS-102 plus pemetrexed and platinum chemotherapy in malignant pleural mesothelioma: a randomized phase 2 study investigating clinical outcomes and the tumor microenvironment

المؤلفون: Ponce, Santiago, Cedrés, Susana, Ricordel, Charles, Isambert, Nicolas, Viteri, Santiago, Herrera-Juarez, Mercedes, Martinez-Marti, Alex, Navarro, Alejandro, Lederlin, Mathieu, Serres, Xavier, Zugazagoitia, Jon, Vetrhus, Sylvia, Jaderberg, Magnus, Hansen, Thomas Birkballe, Levitsky, Victor, Paz-Ares, Luis

المساهمون: Circio Holding ASA

المصدر: Journal for ImmunoTherapy of Cancer ; volume 11, issue 9, page e007552 ; ISSN 2051-1426

الإتاحة: https://doi.org/10.1136/jitc-2023-007552Test

View record in BASE

6

دورية أكاديمية

Tumor microenvironment gene expression profiles associated to complete pathological response and disease progression in resectable NSCLC patients treated with neoadjuvant chemoimmunotherapy

المصدر: Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

مصطلحات موضوعية: Immunoteràpia, Marcadors tumorals, Tumor markers

وصف الملف: 14 p.; application/pdf

العلاقة: Reproducció del document publicat a: https://doi.org/10.1136/jitc-2022-005320Test; Journal for ImmunoTherapy of Cancer, 2022, vol. 10, issue. 9, p. e005320; https://doi.org/10.1136/jitc-2022-005320Test; info:eu-repo/grantAgreement/EC/H2020/875160/EU//CLARIFY; http://hdl.handle.net/2445/190198Test

الإتاحة: https://doi.org/10.1136/jitc-2022-005320Test
http://hdl.handle.net/2445/190198Test

View record in BASE

النص الكامل

7

دورية أكاديمية

COAST : An Open-Label, Phase II, Multidrug Platform Study of Durvalumab Alone or in Combination with Oleclumab or Monalizumab in Patients with Unresectable, Stage III Non-Small-Cell Lung Cancer

المؤلفون: Herbst, Roy S., Majem, Margarita, Barlesi, Fabrice, Carcereny, Enric, Chu, Quincy, Monnet, Isabelle, SÃ¡nchez HernÃ¡ndez, Alfredo, Dakhil, Shaker, Camidge, D, Winzer, Leanne, Soo-Hoo, Yee, Cooper, Zachary A., Kumar, Rakesh, Bothos, John, Aggarwal, Charu, Martinez-Marti, Alex

مصطلحات موضوعية: Antibodies, Monoclonal, Antineoplastic Agents, Carcinoma, Non-Small-Cell Lung, Chemoradiotherapy, Drug Combinations, Humans, Lung Neoplasms, Neoplasm Staging

وصف الملف: application/pdf

العلاقة: Journal of Clinical Oncology; Vol. 3 (january 2022), p. JCO.22.00227; https://ddd.uab.cat/record/282285Test; urn:10.1200/JCO.22.00227; urn:oai:ddd.uab.cat:282285; urn:scopus_id:85131059470; urn:pmid:35452273; urn:articleid:15277755v3JCO.22.00227

الإتاحة: https://ddd.uab.cat/record/282285Test

View record in BASE